RORγt, a multitask nuclear receptor at mucosal surfaces

Mucosal Immunology

Volumn 10, Issue 1, 2017, Pages 27-34

  Eberl, G ^a,b  

^a INSTITUT PASTEUR   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HORMONE RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 5; LYMPHOTOXIN ALPHA BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RETINOIC ACID RELATED ORPHAN RECEPTOR GAMMA T; UNCLASSIFIED DRUG; CHOLESTEROL; RETINOID RELATED ORPHAN RECEPTOR GAMMA;

ALLERGIC REACTION; CIRCADIAN RHYTHM; EPITHELIUM CELL; HOMEOSTASIS; HUMAN; LYMPHOID TISSUE; MICROBIAL IMMUNITY; MUCOSA; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; STEM CELL; TH17 CELL; THYMOCYTE; ANIMAL; GENETICS; HYPERSENSITIVITY; IMMUNOLOGY; INFECTION; INNATE IMMUNITY; LYMPHOCYTE; METABOLISM; MICROFLORA; TRANSCRIPTION INITIATION;

ANIMALS; CHOLESTEROL; CIRCADIAN RHYTHM; HOMEOSTASIS; HUMANS; HYPERSENSITIVITY; IMMUNITY, INNATE; INFECTION; LYMPHOCYTES; MICROBIOTA; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; TRANSCRIPTIONAL ACTIVATION;

EID: 85011101191     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2016.86     Document Type: Review

References (121)

1. Becker-Andre, M., Andre, E. &DeLamarter, J.F. Identification of nuclear receptor mRNAs by RT-PCR amplification of conserved zinc-finger motif sequences. Biochem. Biophys. Res. Commun. 194, 1371-1379 (1993).
2. Carlberg, C., Hooft van Huijsduijnen, R., Staple, J.K., DeLamarter, J.F. &Becker-Andre, M. RZRs, a new family of retinoid-related orphan receptors that function as both monomers and homodimers. Mol. Endocrinol. 8, 757-770 (1994).
3. Giguere, V. et al. Isoform-specific amino-terminal domains dictate DNAbinding properties of ROR alpha, a novel family of orphan hormone nuclear receptors. Genes Dev. 8, 538-553 (1994).
4. Hirose, T., Smith, R.J. &Jetten, A.M. RORg: The third member of ROR/ RZRorphan receptor subfamily that is highly expressed in skeletal muscle. Biochem. Biophys. Res. Commun. 205, 1976-1983 (1994).
5. Medvedev, A., Yan, Z.H.,Hirose, T.,Giguere, V. &Jetten, A.M.Cloning of a cDNA encoding the murine orphan receptor RZR/RORg and characterization of its response element. Gene 181, 199-206 (1996).
6. Becker-Andre, M. et al. Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J. Biol. Chem. 269, 28531-28534 (1994).
7. Wiesenberg, I., Missbach, M., Kahlen, J.P., Schrader, M. &Carlberg, C. Transcriptional activation of the nuclear receptorRZRa by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. Nucleic Acids Res. 23, 327-333 (1995).
8. Carlberg, C. &Wiesenberg, I. The orphan receptor family RZR/ROR, melatonin and 5-lipoxygenase: an unexpected relationship. J. Pineal. Res. 18, 171-178 (1995).
9. He, Y.W., Deftos, M.L., Ojala, E.W. &Bevan, M.J. RORgt, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells. Immunity 9, 797-806 (1998).
10. Sun, Z. et al. Requirement for RORg in thymocyte survival and lymphoid organ development. Science 288, 2369-2373 (2000).
11. Kurebayashi, S. et al. Retinoid-related orphan receptor g (RORg) is essential for lymphoid organogenesis and controls apoptosis during thymopoiesis. Proc. Natl Acad. Sci. USA 97, 10132-10137 (2000).
12. Eberl, G. et al. An essential function for the nuclear receptor RORgt in the generation of fetal lymphoid tissue inducer cells. Nat. Immunol. 5, 64-73 (2004).
13. Mebius, R.E., Streeter, P.R., Michie, S., Butcher, E.C. &Weissman, I.L. A developmental switch in lymphocyte homing receptor and endothelial vascular addressin expression regulates lymphocyte homing and permits CD4+CD3-cells to colonize lymph nodes. Proc. Natl Acad. Sci. USA 93, 11019-11024 (1996).
14. Mebius, R.E., Rennert, P. &Weissman, I.L. Developing lymph nodes collect CD4+CD3-LTb+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7, 493-504 (1997).
15. Adachi, S., Yoshida, H., Kataoka, H. &Nishikawa, S. Three distinctive steps in Peyer's patch formation of murine embryo. Int. Immunol. 9, 507-514 (1997).
16. Cua, D.J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744-748 (2003).
17. Langrish, C.L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233-240 (2005).
18. Ivanov, II et al. The orphan nuclear receptor RORgt directs the differentiation program of proinflammatory IL-17+ T helper cells Cell 126, 1121-1133 (2006).
19. Satoh-Takayama, N. et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29, 958-970 (2008).
20. Luci, C. et al. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat. Immunol. 10, 75-82 (2009).
21. Sanos, S.L. et al. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat. Immunol. 10, 83-91 (2009).
22. Cella, M. et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457, 722-725 (2009).
23. Spits, H. et al. Innate lymphoid cells-A proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145-149 (2013).
24. Spits, H. &Di Santo, J.P. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling Nat. Immunol. 12, 21-27 (2011).
25. Eberl, G., Colonna, M., Di Santo, J.P. &McKenzie, A.N. Innate lymphoid cells: a new paradigm in immunology. Science 348, aaa6566 (2015).
26. Preitner, N. et al. The orphan nuclear receptor REV-ERBa controls circadian transcriptionwithin the positive limb of the mammalian circadian oscillator. Cell 110, 251-260 (2002).
27. Ueda, H.R. et al. A transcription factor response element for gene expression during circadian night. Nature 418, 534-539 (2002).
28. Yu, X. et al. TH17 cell differentiation is regulated by the circadian clock. Science 342, 727-730 (2013).
29. Santori, F.R. et al. Identification of natural RORgamma ligands that regulate the development of lymphoid cells. Cell Metab. 21, 286-297 (2015).
30. Cyster, J.G., Dang, E.V., Reboldi, A. &Yi, T. 25-Hydroxycholesterols in innate and adaptive immunity. Nat. Rev. Immunol. 14, 731-743 (2014).
31. Yoshida, H. et al. IL-7 receptor a+ CD3-cells in the embryonic intestine induces the organizing center of Peyer's patches. Int. Immunol. 11, 643-655 (1999).
32. Honda, K. et al. Molecular basis for hematopoietic/mesenchymal interaction during initiation of Peyer's patch organogenesis. J. Exp. Med. 193, 621-630 (2001).
33. Kim, D. et al. Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE. J. Exp. Med. 192, 1467-1478 (2000).
34. De Togni, P. et al. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264, 703-707 (1994).
35. Rennert, P.D., Browning, J.L., Mebius, R., Mackay, F. &Hochman, P.S. Surface lymphotoxin a/b complex is required for the development of peripheral lymphoid organs. J. Exp. Med. 184, 1999-2006 (1996).
36. Alimzhanov, M.B. et al. Abnormal development of secondary lymphoid tissues in lymphotoxin b-deficient mice. Proc. Natl Acad. Sci. USA 94, 9302-9307 (1997).
37. Dejardin, E. et al. The lymphotoxin-b receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 17, 525-535 (2002).
38. Kanamori, Y. et al. Identification of novel lymphoid tissues in murine intestinal mucosa where clusters of c-kit+ IL-7R+ Thy1+ lymphohemopoietic progenitors develop. J. Exp. Med. 184, 1449-1459 (1996).
39. Eberl, G. &Littman, D.R. Thymic origin of intestinal ab T cells revealed by fate mapping of RORgt+ cells. Science 305, 248-251 (2004).
40. Hamada, H. et al. Identification of multiple isolated lymphoid follicles on the antimesenteric wall of the mouse small intestine. J. Immunol. 168, 57-64 (2002).
41. Lorenz, R.G., Chaplin, D.D., McDonald, K.G., McDonough, J.S. &Newberry, R.D. Isolated lymphoid follicle formation is inducible and dependent upon lymphotoxin-sufficient B lymphocytes, lymphotoxin b receptor, and TNF receptor I function. J. Immunol. 170, 5475-5482 (2003).
42. Tsuji, M. et al. Requirement for lymphoid tissue-inducer cells in isolated follicle formation and T cell-independent immunoglobulin a generation in the gut. Immunity 29, 261-271 (2008).
43. Bouskra, D. et al. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 456, 507-510 (2008).
44. Girardin, S.E. et al. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300, 1584-1587 (2003).
45. McDonald, K.G. et al. CC chemokine receptor 6 expression by B lymphocytes is essential for the development of isolated lymphoid follicles. Am. J. Pathol. 170, 1229-1240 (2007).
46. Lochner,M. et al. Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of RORgt and LTi cells. J. Exp. Med. 208, 125-134 (2011).
47. Aloisi, F. &Pujol-Borrell, R. Lymphoid neogenesis in chronic inflammatory diseases. Nat. Rev. Immunol. 6, 205-217 (2006).
48. Mackley, E.C. et al. CCR7-dependent trafficking of RORgamma(+) ILCs creates a unique microenvironment within mucosal draining lymph nodes. Nat. Commun. 6, 5862 (2015).
49. Sawa, S. et al. Lineage relationship analysis of RORgt+ innate lymphoid cells. Science 330, 665-669 (2010).
50. Reynders, A. et al. Identity, regulation and in vivo function of gut NKp46+RORgammat+ and NKp46+RORgammat-lymphoid cells. EMBO J. 30, 2934-2947 (2011).
51. Satoh-Takayama, N. et al. The chemokine receptor CXCR6 controls the functional topography of Interleukin-22 producing intestinal innate lymphoid cells. Immunity 41, 776-788 (2014).
52. Klose, C.S. et al. AT-bet gradient controls the fate and function of CCR6-RORgammat+ innate lymphoid cells. Nature 494, 261-265 (2013).
53. Crellin, N.K. et al. Regulation of cytokine secretion in human CD127(+) LTi-like innate lymphoid cells by Toll-like receptor 2. Immunity 33, 752-764 (2010).
54. Wang, Y. et al. Lymphotoxin beta receptor signaling in intestinal epithelial cells orchestrates innate immune responses against mucosal bacterial infection. Immunity 32, 403-413 (2010).
55. Kruglov, A.A. et al. Nonredundant function of soluble LTalpha3 produced by innate lymphoid cells in intestinal homeostasis. Science 342, 1243-1246 (2013).
56. Magri, G. et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat. Immunol. 15, 354-364 (2014).
57. Fan, X. &Rudensky, A.Y. Hallmarks of tissue-resident lymphocytes Cell 164, 1198-1211 (2016).
58. Sun, J.C., Beilke, J.N. &Lanier, L.L. Adaptive immune features of natural killer cells. Nature 457, 557-561 (2009).
59. Hernandez, P.P. et al. Interferon-lambda and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection. Nat. Immunol. 16, 698-707 (2015).
60. Sonnenberg, G.F. et al. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 336, 1321-1325 (2012).
61. Sawa, S. et al. RORgammat(+) innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat. Immunol. 12, 320-326 (2011).
62. Aparicio-Domingo, P. et al. Type 3 innate lymphoid cells maintain intestinal epithelial stem cells after tissue damage. J. Exp. Med. 212, 1783-1791 (2015).
63. Lindemans, C.A. et al. Interleukin-22 promotes intestinal-stem-cellmediated epithelial regeneration. Nature 528, 560-564 (2015).
64. Dudakov, J.A. et al. Interleukin-22 drives endogenous thymic regeneration in mice. Science 336, 91-95 (2012).
65. Zenewicz, L.A. et al. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27, 647-659 (2007).
66. Gasteiger, G., Fan, X., Dikiy, S., Lee, S.Y. &Rudensky, A.Y. Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs. Science 350, 981-985 (2015).
67. Kirchberger, S. et al. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J. Exp. Med. 210, 917-931 (2013).
68. Buonocore, S. et al. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464, 1371-1375 (2010).
69. Geremia, A. et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J. Exp. Med. 208, 1127-1133 (2011).
70. Kim, H.Y. et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat. Med. 20, 54-61 (2014).
71. Burcelin, R., Garidou, L. &Pomie, C. Immuno-microbiota cross and talk: The new paradigm of metabolic diseases. Semin. Immunol. 24, 67-74 (2012).
72. Hepworth, M.R. et al. Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature 498, 113-117 (2013).
73. von Burg, N. et al. Activated group 3 innate lymphoid cells promote T-cellmediated immune responses. Proc. Natl Acad. Sci. USA 111, 12835-12840 (2014).
74. Mortha, A. et al. Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science 343, 1249288 (2014).
75. Solt, L.A. et al. Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand. Nature 472, 491-494 (2011).
76. Huh, J.R. et al. Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORgammat activity. Nature 472, 486-490 (2011).
77. Withers, D.R. et al. Transient inhibition of ROR-gammat therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells. Nat. Med. 22, 319-323 (2016).
78. Guo, J. et al. Regulation of the TCRa repertoire by the survival window of CD4+CD8+ thymocytes. Nat. Immunol. 3, 469-476 (2002).
79. Sutton, C., Brereton, C., Keogh, B., Mills, K.H. &Lavelle, E.C. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203, 1685-1691 (2006).
80. Harrington, L.E. et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123-1132 (2005).
81. Mangan, P.R. et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441, 231-234 (2006).
82. Bettelli, E. et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441, 235-238 (2006).
83. Zhou, L. et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453, 236-240 (2008).
84. Harris, T.J. et al. Cutting edge: an in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity. J. Immunol. 179, 4313-4317 (2007).
85. Sato, K. et al. Th17 functions as an osteoclastogenic helper Tcell subset that links Tcell activation and bone destruction. J. Exp. Med. 203, 2673-2682 (2006).
86. Hirota, K. et al. Tcell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J. Exp. Med. 204, 41-47 (2007).
87. Elson, C.O. et al. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology 132, 2359-2370 (2007).
88. Kastelein, R.A., Hunter, C.A. &Cua, D.J. Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation. Annu. Rev. Immunol. 25, 221-242 (2007).
89. Aujla, S.J. et al. IL-22 mediates mucosal host defense against Gramnegative bacterial pneumonia. Nat. Med. 14, 275-281 (2008).
90. Khader, S.A., Gaffen, S.L. &Kolls, J.K. Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa. Mucosal Immunol. 2, 403-411 (2009).
91. Sano, T. et al. An IL-23R/IL-22 circuit regulates epithelial serum amyloid A to promote local effector Th17 responses. Cell 163, 381-393 (2015).
92. Atarashi, K. et al. ATP drives lamina propria T(H)17 cell differentiation. Nature 455, 808-812 (2008).
93. Ivanov, I.I. et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485-498 (2009).
94. Gaboriau-Routhiau, V. et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31, 677-689 (2009).
95. Atarashi, K. et al. Th17 cell induction by adhesion ofmicrobes to intestinal epithelial cells. Cell 163, 367-380 (2015).
96. Lochner, M. et al. In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgt+ T cells. J. Exp. Med. 205, 1381-1393 (2008).
97. Wohlfert, E. &Belkaid, Y. Plasticity of T reg at infected sites. Mucosal Immunol. 3, 213-215 (2010).
98. Yang, B.H. et al. Foxp3(+) T cells expressing RORgammat represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation. Mucosal Immunol. 9, 444-457 (2016).
99. Blatner, N.R. et al. Expression of RORgammat marks a pathogenic regulatory T cell subset in human colon cancer. Sci. Transl. Med. 4, 164ra159 (2012).
100. Ohnmacht, C. et al. The microbiota regulates type 2 immunity through RORgt+ T cells. Science 349, 989-993 (2015).
101. Sefik, E. et al. Individual intestinal symbionts induce a distinct population of RORgamma(+) regulatory T cells. Science 349, 993-997 (2015).
102. Schiering,C. et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 513, 564-568 (2014).
103. Wohlfert, E.A. et al. GATA3 controls Foxp3(+) regulatory Tcell fate during inflammation in mice. J. Clin. Invest. 121, 4503-4515 (2011).
104. Eberl, G. Immunity by Equilibrium. Nat. Rev. Immunol. 16, 524-532 (2016).
105. Taylor, P.R. et al. Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORgammat and dectin-2. Nat. Immunol. 15, 143-151 (2014).
106. Savers, A. et al. Infection-mediated priming of phagocytes protects against lethal secondary aspergillus fumigatus challenge. PLoS One 11, e0153829 (2016).
107. Ferretti, S., Bonneau, O., Dubois, G.R., Jones, C.E. &Trifilieff, A. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger J. Immunol. 170, 2106-2112 (2003).
108. Kallen, J.A. et al. X-ray structure of the hRORalpha LBD at 1.63 A: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha. Structure. 10, 1697-1707 (2002).
109. Soroosh, P. et al. Oxysterols are agonist ligands of RORgammat and drive Th17 cell differentiation. Proc. Natl Acad. Sci. USA 111, 12163-12168 (2014).
110. Xu, T. et al. Ursolic acid suppresses interleukin-17 (IL-17) production by selectively antagonizing the function of RORgamma t protein. J. Biol. Chem. 286, 22707-22710 (2011).
111. Huh, J.R. &Littman, D.R. Small molecule inhibitors of RORgammat: Targeting Th17 cells and other applications. Eur. J. Immunol. 42, 2232-2237 (2012).
112. Teng, M.W. et al. IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases. Nat. Med. 21, 719-729 (2015).
113. Kathania, M. et al. Itch inhibits IL-17-mediated colon inflammation and tumorigenesis by ROR-gammat ubiquitination. Nat. Immunol. 17, 997-1004 (2016).
114. Jianjun, Y. et al. Tcell-derived inducible nitric oxide synthase switches off Th17 cell differentiation. J. Exp. Med. 210, 1447-1462 (2013).
115. Lazarevic, V. et al. T-bet represses T(H)17 differentiation by preventing Runx1-mediated activation of the gene encoding RORgammat. Nat. Immunol. 12, 96-104 (2011).
116. Gascoyne, D.M. et al. The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nat. Immunol. 10, 1118-1124 (2009).
117. Geiger, T.L. et al. Nfil3 is crucial for development of innate lymphoid cells and host protection against intestinal pathogens. J. Exp. Med. 211, 1723-1731 (2014).
118. Seillet, C. et al. Nfil3 is required for the development of all innate lymphoid cell subsets. J. Exp. Med. 211, 1733-1740 (2014).
119. Xu, W. et al. Nfil3 orchestrates the emergence of common helper innate lymphoid cell precursors. Cell Rep. 10, 2043-2054 (2015).
120. Takeda, Y., Jothi, R., Birault, V. &Jetten, A.M. RORgamma directly regulates the circadian expression of clock genes and downstream targets in vivo. Nucleic Acids Res. 40, 8519-8535 (2012).
121. Kojetin, D.J. &Burris, T.P. REV-ERB and ROR nuclear receptors as drug targets. Nat. Rev. Drug. Discov. 13, 197-216 (2014).